BR112017007754B1 - Composições de ácido graxo monoinsaturado e uso no tratamento de aterosclerose - Google Patents

Composições de ácido graxo monoinsaturado e uso no tratamento de aterosclerose Download PDF

Info

Publication number
BR112017007754B1
BR112017007754B1 BR112017007754-0A BR112017007754A BR112017007754B1 BR 112017007754 B1 BR112017007754 B1 BR 112017007754B1 BR 112017007754 A BR112017007754 A BR 112017007754A BR 112017007754 B1 BR112017007754 B1 BR 112017007754B1
Authority
BR
Brazil
Prior art keywords
composition
weight
fatty acids
fatty acid
mufa
Prior art date
Application number
BR112017007754-0A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112017007754A2 (pt
Inventor
John M. Burke
Original Assignee
Burke & Boyer Nyc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Burke & Boyer Nyc filed Critical Burke & Boyer Nyc
Publication of BR112017007754A2 publication Critical patent/BR112017007754A2/pt
Publication of BR112017007754B1 publication Critical patent/BR112017007754B1/pt

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
BR112017007754-0A 2014-10-15 2015-10-14 Composições de ácido graxo monoinsaturado e uso no tratamento de aterosclerose BR112017007754B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462064207P 2014-10-15 2014-10-15
US62/064,207 2014-10-15
PCT/US2015/055504 WO2016061207A1 (en) 2014-10-15 2015-10-14 Monounsaturated fatty acid compositions and use for treating atherosclerosis

Publications (2)

Publication Number Publication Date
BR112017007754A2 BR112017007754A2 (pt) 2018-08-28
BR112017007754B1 true BR112017007754B1 (pt) 2023-04-11

Family

ID=55747261

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017007754-0A BR112017007754B1 (pt) 2014-10-15 2015-10-14 Composições de ácido graxo monoinsaturado e uso no tratamento de aterosclerose

Country Status (8)

Country Link
US (1) US9808437B2 (https=)
EP (1) EP3206677A4 (https=)
JP (2) JP6840671B2 (https=)
CN (2) CN106794165A (https=)
BR (1) BR112017007754B1 (https=)
CA (1) CA2963980A1 (https=)
MX (1) MX2017004839A (https=)
WO (1) WO2016061207A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7602315B2 (ja) * 2018-10-16 2024-12-18 株式会社ニッスイ 血清中ｔｍａｏ低減用組成物
EP4017484A4 (en) * 2019-08-21 2022-10-19 Burke & Boyer, Inc. MONOUNSATURATED FATTY ACID COMPOSITION AND USE TO TREAT FAT LIVER DISEASE
AU2022289040A1 (en) * 2021-06-11 2023-12-14 Nourish Ingredients Pty Ltd Production of saturated fats in microbes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5198250A (en) * 1990-07-16 1993-03-30 Lipotech Partners Limited Partnership Food and pharmaceutical compositions containing short chain monounsaturated fatty acids and methods of using
US5959131A (en) * 1995-12-07 1999-09-28 Kraft Foods, Inc. Nutritionally superior fat for food compositions
US6391369B1 (en) 1996-03-27 2002-05-21 Bunge Foods Corporation Selectively hydrogenated high oleic oil compositions and process
US6183796B1 (en) * 1999-09-20 2001-02-06 Lipotech Partners Limited Partnership Monounsaturated fatty acid compositions and method of making
WO2007111992A2 (en) * 2006-03-22 2007-10-04 President And Fellows Of Harvard College Methods and compositions for treating hypercholesterolemia and atherosclerosis
US20090311367A1 (en) * 2008-06-17 2009-12-17 Perry Stephen C Dietary Supplement
CA2750153C (en) * 2009-01-05 2016-11-08 Calanus As Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
JP6206937B2 (ja) * 2010-10-08 2017-10-04 和久 前田 マッサージ施療による経皮投与用の血流依存性血管拡張反応改善剤及び血糖値低下剤、並びに生体用貼付シート
MX2013010076A (es) * 2011-03-03 2014-04-07 Tersus Pharmaceuticals Llc Composiciones y metodos que comprenden c16:1n7 palmitoleato.
ITMI20111284A1 (it) * 2011-07-11 2013-01-12 Giovanni Nusca Composizione farmaceutica.
WO2014054048A1 (en) * 2012-10-01 2014-04-10 Dow Global Technologies Llc Triglyceride based, low viscosity, high flash point dielectric fluids

Also Published As

Publication number Publication date
CA2963980A1 (en) 2016-04-21
EP3206677A4 (en) 2018-04-25
JP2020182497A (ja) 2020-11-12
CN113244206A (zh) 2021-08-13
MX2017004839A (es) 2017-10-12
BR112017007754A2 (pt) 2018-08-28
WO2016061207A1 (en) 2016-04-21
US20170216237A1 (en) 2017-08-03
US9808437B2 (en) 2017-11-07
JP2017532381A (ja) 2017-11-02
CN106794165A (zh) 2017-05-31
JP6840671B2 (ja) 2021-03-10
EP3206677A1 (en) 2017-08-23

Similar Documents

Publication Publication Date Title
Stahl et al. The role of omega-3 fatty acids in mood disorders
DE69823548T2 (de) Verwendung von mehrfach ungesättigten fettsäuren zur vorbeugung von nekrotizierender enterokolitis
SE448678B (sv) Farmaceutisk beredning som vesentligen bestar av eikosapentaensyra eller derivat derav
AU2005311266A1 (en) Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by anti-retroviral treatment of HIV-infected patients
GB2033745A (en) Fatty acid and derivatives thereof in treatment or prophylaxis of thrombo-embolic conditions
JP2509810B2 (ja) 中鎖トリグリセライドの内臓へ向けられた代謝のための非経口脂質エマルジョン
JP2022538212A (ja) 疾患の治療および軽減のための超長鎖脂肪酸
Richardson et al. Electrophysiological mechanisms of the anti-arrhythmic effects of omega-3 fatty acids
JP2020182497A (ja) 一価不飽和脂肪酸組成物およびアテローム性動脈硬化症を処置するための使用
JPS62265222A (ja) 細胞膜の脂質構造および機能の修飾法並びにこれに使用する製剤組成物
CN102416056A (zh) 一种降血脂复方纳米乳口服液及其制备方法
EP1004303B1 (en) Composition having capability of removing risk factor during exercise
JPS5841825A (ja) 非経口投与用脂肪エマルジヨン
CN114306319B (zh) 神经酸在修复脑缺血再灌注损伤中的应用
HK40057957A (en) Monounsaturated fatty acid compositions and use for treating atherosclerosis
HK1238139A1 (en) Monounsaturated fatty acid compositions and use for treating atherosclerosis
JP2022544847A (ja) 一価不飽和脂肪酸組成物及び脂肪性肝疾患を治療するための使用
JPH01156922A (ja) 悩疾患治療用薬剤の製造方法と治療用化合物
JP5504405B2 (ja) 血管病予防に効果を有する食品組成物
RU2387448C2 (ru) Незаменимые жирные кислоты, предназначенные для предупреждения и/или лечения депрессии у пациентов, страдающих коронарной болезнью сердца или болезнью коронарной артерии
JP2000302677A (ja) カルニチン自己産生能改善作用を有する医薬および食品・飼料組成物
JPH11239464A (ja) 運動時の危険因子除去能を有する組成物
JP4139677B2 (ja) 記憶障害改善作用を有する組成物
BR112022015709B1 (pt) Composição nutracêutica e uso de dita composição
JPH10147523A (ja) 血液流動性改善作用を有する医薬及び食品・飼料組成物

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/10/2015, OBSERVADAS AS CONDICOES LEGAIS